Amino Acid PET in Neurooncology
Journal of Nuclear Medicine · 2023-05 · 64 (5) · 693-700
DOI: 10.2967/jnumed.122.264859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 13.04.2023. Verfasst von Norbert Galldiks und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany; norbert.galldiks@uk-koeln.de. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 140 Literaturangaben.
Abstract (Originalsprache)
For decades, several amino acid PET tracers have been used to optimize diagnostics in patients with brain tumors. In clinical routine, the most important clinical indications for amino acid PET in brain tumor patients are differentiation of neoplasm from nonneoplastic etiologies, delineation of tumor extent for further diagnostic and treatment planning (i.e., diagnostic biopsy, resection, or radiotherapy), differentiation of treatment-related changes such as pseudoprogression or radiation necrosis after radiation or chemoradiation from tumor progression at follow-up, and assessment of response to anticancer therapy, including prediction of patient outcome. This continuing education article addresses the diagnostic value of amino acid PET for patients with either glioblastoma or metastatic brain cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany; norbert.galldiks@uk-koeln.de.
- Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany.
- Center for Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany; and.
- Department of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
- Department of Nuclear Medicine, RWTH University Hospital Aachen, Aachen, Germany.
Zitieren
APA
Galldiks, N., Lohmann, P., Fink, G. R., & Langen, K. J. (2023). Amino Acid PET in Neurooncology. Journal of Nuclear Medicine, 64(5), 693-700. https://doi.org/10.2967/jnumed.122.264859
Vancouver
Galldiks N, Lohmann P, Fink GR, Langen KJ. Amino Acid PET in Neurooncology. Journal of Nuclear Medicine. 2023;64(5):693-700. doi:10.2967/jnumed.122.264859
BibTeX
@article{Galldiks2023,
author = {Galldiks, Norbert and Lohmann, Philipp and Fink, Gereon R and Langen, Karl-Josef},
title = {Amino Acid PET in Neurooncology},
journal = {Journal of Nuclear Medicine},
year = {2023},
volume = {64},
number = {5},
pages = {693--700},
doi = {10.2967/jnumed.122.264859}
}
EUVIMED